糖尿病的病因探讨(4)
[19] Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons.Diabetes,2008,57(11):2863-2871. ID:18971433
[20] Jaidane H,Sauter P,Sane F,et al. Enteroviruses and type 1 diabetes:towards a better understanding of the relationship.Rev Med Virol,2010,20:11-16. ISSN:10529276
[21] Bener A,Alsaled A,Al-Ali M,et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children.Acta Diabetetol,2009,46:183-189. DOI:10.1007/s00592-008-0071-6
[22] Couper JJ,Beresford S,Hirte C,et al. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes.Diabetes Care,2009,32:94-99. DOI:10.2337/dc08-0821
[23] Aljabri KS,Bokhari SA,Khan MJ et al. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency.Ann Saudi Med,2010,30(6):454-458. DOI:10.4103/0256-4947.72265
[24] Parks M,Rosebraugh C. Weighing risks and benefits of liraglutide-the FDA′s review of a new antidiabetic therapy.N Engl J Med,2010,362(9):774-777. ID:20164475
[25] DeFronzo RA,Ratner RE,Han J,et al.Effects of exenatide(exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.Diabetes Care,2005,28(5):1092-1100. ID:15855572, 百拇医药(邵惠训)
[20] Jaidane H,Sauter P,Sane F,et al. Enteroviruses and type 1 diabetes:towards a better understanding of the relationship.Rev Med Virol,2010,20:11-16. ISSN:10529276
[21] Bener A,Alsaled A,Al-Ali M,et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children.Acta Diabetetol,2009,46:183-189. DOI:10.1007/s00592-008-0071-6
[22] Couper JJ,Beresford S,Hirte C,et al. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes.Diabetes Care,2009,32:94-99. DOI:10.2337/dc08-0821
[23] Aljabri KS,Bokhari SA,Khan MJ et al. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency.Ann Saudi Med,2010,30(6):454-458. DOI:10.4103/0256-4947.72265
[24] Parks M,Rosebraugh C. Weighing risks and benefits of liraglutide-the FDA′s review of a new antidiabetic therapy.N Engl J Med,2010,362(9):774-777. ID:20164475
[25] DeFronzo RA,Ratner RE,Han J,et al.Effects of exenatide(exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.Diabetes Care,2005,28(5):1092-1100. ID:15855572, 百拇医药(邵惠训)